adf5646

download adf5646

of 24

Transcript of adf5646

  • 8/6/2019 adf5646

    1/24

    1

    Indian Ayurvedic System of Medicine: Scope forNew Drug Design and Discovery

    Dr. Narshinha P. Argade

    Division of Organic ChemistryNational Chemical Laboratory, Pune 411 008

    INDIA

    [email protected]

  • 8/6/2019 adf5646

    2/24

    2Saraswati: Godess of KnowledgeMother of Vedas

    Dhanwantari: Physician of GodsFather and Promulgator of Ayurveda

    Guru-Shishya Tradition

    INDIA / CHINA

  • 8/6/2019 adf5646

    3/24

    3

    World of Ayurveda: Rich Repository of Original Knowledge Charak Samhita Sushruta Samhita Madhava Nidana Astanga Haridaya

    Indian area: 2.4% of the world with range of geoclimatic conditions Indian biodiversity: 8.1% of the world Indian Plant Species: 45000 (3000 used in Ayurveda) Indian Ayurvedic formulations: 35000 + Bhasmas Indian Registered Ayurvedic Practitioners: 6,00,000

    http://images.google.co.in/imgres?imgurl=http://lh6.ggpht.com/_PDHWS6OSLfU/R3s8yg1ApPI/AAAAAAAAEYY/Dt95rvEk1fQ/P1010218.JPG&imgrefurl=http://picasaweb.google.com/lh/photo/Y_AhgWh_zJ68TeVqAv_v3w&h=1712&w=2288&sz=175&hl=en&start=9&um=1&tbnid=fV3PCl1m-bAXkM:&tbnh=107&tbnw=143&prev=/images%3Fq%3DPicture%2Bof%2Bdense%2BIndian%2Bforest%26um%3D1%26hl%3Den%26sa%3DXhttp://images.google.co.in/imgres?imgurl=http://www.northindiatours.indianconsultancy.com/gifs/north-india-forest.jpg&imgrefurl=http://www.northindiatours.indianconsultancy.com/&h=239&w=261&sz=17&hl=en&start=15&um=1&tbnid=qW7SdaljSwWYfM:&tbnh=103&tbnw=112&prev=/images%3Fq%3DPicture%2Bof%2Bdense%2BIndian%2Bforest%26um%3D1%26hl%3Den%26sa%3DX
  • 8/6/2019 adf5646

    4/24

    4

    Development of Ayurvedic FormulationsObservationHypothesis formulationTesting by experimentsInduction derived general principleApplication of general principle

    http://www.organicindia.com/images/ayurveda.jpg
  • 8/6/2019 adf5646

    5/24

    5

    Disease Plant species Common nameMultiresistant Tuberculosis Cyperus rotundus Motha

    Obesity & heart diseases Commiphora mukul Guggulu

    Cancer Rubia cordifolia Manjistha

    Diabetes Petrocarpus marsupium Vijaysar

    Asthma Adhatoda vasica Adhulsa

    Hepatitis Peganum nigellastrum Syrian rue

    Diseases and Ayurvedic Medicines

  • 8/6/2019 adf5646

    6/24

    6

    Comparison of Ayurvedic System of Medicine with AllopathyAyurvedic System Allopathic System

    Experiential Experimental

    Reductionistic

    Health oriented Disease oriented

    Diet oriented Drug and surgery orientedGreen pharmacy Red pharmacy

    Pro-nature Anti-nature

    Client oriented Profession orientedActive on all humans Active on 30% humans

    No side effects Side effects

    Mode of action unknown Mode of action known ?

    Slow effects Fast effects

    Holistic

    Philophical Physical

  • 8/6/2019 adf5646

    7/24

    7

    First Institute of AyurvedicEducation: Gurukul Kangdi

    Ayurvedic Colleges in India: 210

    BAMS: 8000

    MAMS: 600 I Desire that the Diseases andMiseries of all Living Beings areResolved

    Shri Zandu Bhattji

  • 8/6/2019 adf5646

    8/24

    8

    Natural Products Derived Drugs 1998-2004

  • 8/6/2019 adf5646

    9/24

    9

    New Drug Discovery @ NCL

    N

    N

    O

    OH

    NH

    NN

    O

    O

    OH

    O

    O

    O

    O

    O

    O

    O

    HO

    HO

    H

    H

    H

    H

    AssayDevelopment

    High-ThroughputScreening

    Separation

    Parallel

    Synthesis

    Evaporation

    Extraction

    Hits & Leads

    NewDrugs

    Natural Products

    Synthetic Products

  • 8/6/2019 adf5646

    10/24

    10

    Dr. G. V. Satyavati

    1966-Guggulu Girl

    O

    O

    Z-Guggulsterone

    (Cholesterol Lowering Agent)

    G. V. Satyavati et al. Ind. J. Med. Res. 1988, 87, 327.

    Commiphora mukul

  • 8/6/2019 adf5646

    11/24

    11

    A Natural Product That Lowers Cholesterol As anAntagonist Ligand for FXRNancy L. Urizar, Amy B. Liverman, DNette T. Dodds, Frank Valentin Silva,Peter Ordentlich, Yingzhuo Yan, Frank J. Gonzalez, Richard A. Heyman, David

    J. Mangelsdorf, David D. Moore*

    The gum resin of Commiphora mukul (guggulu in Sanskrit)has been used in Ayurvedic medicine since at least 600 BC totreat a wide variety of ailments, including obesity and lipiddisorders.

    Science 2002,296, 1703.

  • 8/6/2019 adf5646

    12/24

    12

    (-)-Vasicine, (-)-Vasicinone and Isovasicinone

    N

    N

    O

    OH(-)-Vasicinone

    N

    N

    OH(-)-Vasicine

    Iso la t ion: A d h a t o d a v a s i c a

    Act i v it y : Used in The Indian Ayurvedic Sys tem o f

    Medic ine as a remedy fo r cough, co ld and

    bronch i t i s

    N

    N

    O OH

    Isovasicinone

  • 8/6/2019 adf5646

    13/24

    13

    N

    N

    O

    N

    N

    O

    OH

    Davis reagent

    -78 oC

    39% (71% ee)

    Earlier Approaches towards Vasicinone

    Eguchi et al. J. Org. Chem. 1996, 61, 7316.

    N

    N

    O

    OHN

    N

    O

    OAc

    Amano PS, VA

    THF

    45% (100% ee)

    Kamal et al. J. Org. Chem. 2001, 66, 997.

  • 8/6/2019 adf5646

    14/24

    14

    NCL-Synthesis of (-)-Vasicinone

    NH2

    NH2

    O

    O

    O

    OOAc

    +

    CONH2

    NH

    OHOO

    OAc

    CONH2

    NH

    OO

    OMe

    OAc

    CONH2

    NH

    OOH

    OH

    N

    NHOH

    O

    OH

    N

    N

    O

    OH

    (98%) (98%)

    (92%)

    (90%)

    7 6

    2 3 45

    (-)-Vasicinone (1)

    Ether CH2N2

    (a) LAH(b) H2O

    DEAD,TPP

    S. B. Mhaske and N. P. Argade J. Org. Chem. 2001, 66, 9038.

  • 8/6/2019 adf5646

    15/24

    15

    Synthesis of (-)-Vasicine - in Progress

    TFA

    NH2

    NHBocO

    O

    OOAc

    +NH

    OHOO

    OAc

    NHBoc

    NH

    OO

    OMe

    OAc

    NHBoc

    NH

    OOH

    OH

    NHBoc

    N

    NHOH

    OH

    N

    N

    OH

    (95%) (87%)

    7 6

    2 3 4 5

    (-)-Vasicine (1)

    Ether CH2N2

    LAH, THF(73%)

    ?X

  • 8/6/2019 adf5646

    16/24

  • 8/6/2019 adf5646

    17/24

    17

    Batey et al. Org. Lett. 2004, 6, 4913.

    Yao et al.J. Org. Chem. 2007, 72, 6270.

    N

    N

    H

    O

    O

    N

    O

    N

    N

    Aniline, Dy(OTf)3

    (51%)

    N

    N

    O

    O

    NH

    Ph3PO, Tf2O

    (99%)

    1

    2

    Earlier Approaches towards Luotonin A

  • 8/6/2019 adf5646

    18/24

    18

    An Efficient Biogenetic Total Synthesis of Luotonin F

    NH2

    O

    NH2 +

    1

    O

    O

    O

    N

    NH

    O

    OH

    N

    N

    O OH

    Pegamine

    N

    N

    NH

    O

    2

    (93%)

    (96%)(62%)

    Deoxoluotonin F (8)

    NH

    CONH2O COOH

    NH

    CONH2O

    COOMe

    43

    Et2O

    (98%) (98%)

    CH2N2

    (i) LAH/THF(ii) H2O

    PCC

    (64%)

    Isovasicinone (7)

    o-Amino-benzaldehyde,KOH CrO3/H5IO6

    [5]NH

    CONH2O

    OH

    N

    NH

    O

    CHO

    [6]

    N

    N

    NH

    O

    O

    Luotonin F

    Practical Synthesis of Luotonin A and Luotonin B & E via

  • 8/6/2019 adf5646

    19/24

    19

    Practical Synthesis of Luotonin A and Luotonin B & E via

    Novelortho-Directed Lithiation

    NH2

    NH2

    O

    NCl

    ON

    NH

    N

    O

    NH

    O

    N

    CONH2

    N

    N

    N

    O

    N

    NH

    N

    O OH

    N

    N

    N

    O

    N

    N

    N

    O OMe

    N

    N

    N

    O OH

    N

    NLi

    N

    OCHO

    +

    Luotonin A (1a)

    Luotonin B (1b)Luotonin E (1c)

    i ii

    iiia

    iv

    iiic

    iiib

    v

    vi

    2 3 4 5

    [6]7

    [8]

    LiLi

    (96%) (98%)

    (86%)

    (81%)

    (95%)

    (61%)

    (82%)

    8

    3`

    8`

    Reagents,condition and Yields: (i) TEA (2 eq.), THF, rt, 3 h (96%); (ii) 5% aq. KOH, EtOH, reflux, 5 min. (98%); (iiia) Mesityllithium (2.2 eq.), 78 oC, 1 h to 20 oC (gradually), (iiib) THF solution of HCHO (5 eq.), 30 oC, 20 min., saturated aq. solution ofNH4Cl (86%), (iiic) DMF (5 eq.),

    20

    o

    C, 30 min., saturated aq. solution of NH4Cl (81%); (iv) PPh3 (1.3 eq.), DEAD (1.2 eq.), THF,rt, 1 h (95%); (v) PCC (1.2 eq.), powdered 4 molecular sieves, DCM, rt, 1 h (61%); (vi)p-TSA (5 eq.), MeOH, reflux, 3 h (82%).

    S. B. Mhaske and N. P. ArgadeJ. Org. Chem. 2004, 69, 4563.

  • 8/6/2019 adf5646

    20/24

    20

    NH

    NH2MeO

    O

    O

    O

    CH3

    +

    MeON

    NH

    CH3

    HOOC

    Luotonin C (1)

    N

    NMeO

    O

    CH3

    MeON

    CH3

    N

    O

    NHNH

    MeOO

    CH3

    HOOC

    2 3 4

    5 6

    Synthesis of Luotonins C, in Progress

    P. B. Wakchaure and N. P. Argade (Unpublished results).

  • 8/6/2019 adf5646

    21/24

    21

    Indian AyurvedicSystem of Medicine Chemist Doctor

    Safe but slow Fast and moresafe

    A k l d t

    http://images.google.co.in/imgres?imgurl=http://www.saunalahti.fi/~marian1/gourmet/pic/s_sand.jpg&imgrefurl=http://www.saunalahti.fi/~marian1/gourmet/i_sugars.htm&h=170&w=170&sz=10&hl=en&start=245&um=1&tbnid=RvF8UWL2dGMtNM:&tbnh=99&tbnw=99&prev=/images%3Fq%3Dphoto%2Bof%2Bcoloured%2Bcrystalline%2Bcompound%26start%3D240%26ndsp%3D20%26um%3D1%26hl%3Den%26sa%3DN
  • 8/6/2019 adf5646

    22/24

    22

    Acknowledgements

    Aquapharm Ltd., PuneRecon Ltd., BangaloreGodrej Agrovet, MumbaiParke-Davis, USAYamanuchi, JapanNikem, ItalyDST, New DelhiCSIR, New DelhiICS-UNIDO, ItalyDr. G. P. Pandey, HeadDOC, NCL, PuneDr. S. Sivaram, DirectorNCL, Pune, India

    Dr. S. B. DesaiDr. A. M. DeshpandeDr. S. MangaleswaranDr. S. B. MhaskeDr. Anirban KarDr. S. EaswarDr. M. MondalDr. Merajuddin BaagDr. Sanjib GogoiMr. Kishan Haval (SRF)Mr. Umesh Kshirsagar (SRF)Mr. Ramesh Patel (SRF)Mr. Prasad Wakchaure (SRF)Mr. Mandeep Singh (JRF)Mr. Prashant Deore (JRF)

    Th f thi l b t i t d k l d

  • 8/6/2019 adf5646

    23/24

    23

    www.ncl-india.org

    The purpose of this laboratory is to advance knowledgeand apply chemical science for the good of the people

    National Chemical Laboratory, Pune, India

  • 8/6/2019 adf5646

    24/24